COVID-19, with persistent and new onset of symptoms such as fatigue, post-exertional
malaise, and cognitive dysfunction that last for months and impact everyday functioning, is …

With a global tally of more than 500 million cases of severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2) infections to date, there are growing concerns about the post …

SARS-CoV-2 infection for most children results in mild or minimal symptoms, though in rare
cases severe disease can develop, including a multisystem inflammatory syndrome (MIS-C) …

Post‐acute sequelae of COVID‐19 (PASC) are long‐term consequences of SARS‐CoV‐2
infection that can substantially impair the quality of life. Underlying mechanisms ranging …

In the beginning of COVID-19, the proportion of confirmed cases in the pediatric population
was relatively small and there was an opinion that children often had a mild or asymptomatic …

Multisystem inflammatory syndrome in children (MIS-C) is a delayed-onset, COVID-19-
related hyperinflammatory illness characterized by severe acute respiratory syndrome …

Omicron variants of SARS-CoV-2 are globally dominant and infection rates are very high in
children. We measure immune responses following Omicron BA. 1/2 infection in children …

Although children are likely to have a milder COVID-19 course compared with adults, MIS-C
as a postinfectious and life-threatening complication was reported in the pediatric age. After …

Immune responses following severe acute respiratory syndrome coronavirus 2 (SARS-CoV-
2) in children are still under investigation. Even though coronavirus disease 2019 (COVID …

Objectives To comprehensively analyze the quality of the antibody response between
children with Multisystem inflammatory syndrome (MIS-C) and age-matched controls at one …